Preview Mode Links will not work in preview mode

This Week in Cardiology

Nov 10, 2023

Renal denervation, a potential deadly decision in the ED, GLP-1 agonists, and an AHA preview are the topics John Mandrola, MD, discusses in this week’s podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. Renal Denervation

FDA OKs Paradise Renal Denervation System for Hypertension

- Company Press Release

- Six-month Meta-analysis of RDN Studies

- March This Week in Cardiology with RDN Discussion

II. Potential Deadly Decisions in the ED

Even One Night in the ED Raises Risk for Death

- JAMA Internal Medicine Study

III. Tirzepatide Approval

FDA Approves Tirzepatide for Treating Obesity



IV. AHA Preview

Mandrola's Top Trials to Look for at AHA 2023

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact